i10 Productivity
Rankings
AbbVie Inc Scientists i10 Productivity Rankings (Sort by last 6 years i10 Index) 2025
Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :76
Computational Models
Biomaterials
Drug Delivery
Stem Cells
Toxicology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :77
Statistical learning
clinical development
rare disease
oncology
RWE
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
18
0.947
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :78
Immunology
Innate Immunity
Chronic Inflammation
Auto-immune diseases
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :79
Synthetic chemistry
Process development
Solid from screening of active ingredients
Analytical
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :80
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :81
Mass Spectrometry
Drug Discovery
High-Throughput Screening
Analytical Chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :82
Cell Biology
Development
Proteostasis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :83
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :84
Pathology
Bioengineering
Development
Metabolism
Stem Cells
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :85
statistics
clinical trials
adaptive design
real world data
inflammatory bowl disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :86
Immunology
Autoimmunity
Molecular Biology
SLE
PI3K
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :87
Amorphous
Dissolution
Absorption
Solubility enhancement
Crystallization
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :88
Imaging
PET
Neuroscience
Biomathematics
Analysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :89
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :90
Health Economics and Outcomes Research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :91
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :92
Idiopathic Lung Fibrosis
Myopathies
diabetic nephropathy
renal osteodystrophy
podocytopathy
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :93
Covalent inhibitors
Organic synthesis
Cysteine Oxidation
Medicinal Chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :94
Mass spectrometry
Imaging mass spectrometry
Organic chemistry
pharmacetical
DMPK
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :95
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :96
Medicinal Chemistry
Targeted Protein Degradation
Parallel Synthesis
Organic Synthesis
Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
29
15
0.517
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :97
Medical image analysis
Signal processing
Medical image computing
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
15
0.625
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :98
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
15
0.625
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :99
PBPK
Drug Transporters
Drug Metabolism
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
15
0.882
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :100
Biomarkers
Oncology
Cancer biology
Hypoxia
Apoptosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
15
15
1.000
David Belair
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
Computational Models
Biomaterials
Drug Delivery
Stem Cells
Toxicology
Tu Xu
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
18
0.947
Statistical learning
clinical development
rare disease
oncology
RWE
Yunhao Tan
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
Immunology
Innate Immunity
Chronic Inflammation
Auto-immune diseases
Vijith Kumar
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
Synthetic chemistry
Process development
Solid from screening of active ingredients
Analytical
Ahmad Y Sheikh
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
Fan Pu
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Mass Spectrometry
Drug Discovery
High-Throughput Screening
Analytical Chemistry
Christian Pohl
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Cell Biology
Development
Proteostasis
Juki Ng
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Kevin Kolahi
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Pathology
Bioengineering
Development
Metabolism
Stem Cells
Tian Feng
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
statistics
clinical trials
adaptive design
real world data
inflammatory bowl disease
Abel Suarez-Fueyo
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
Immunology
Autoimmunity
Molecular Biology
SLE
PI3K
Anura Indulkar
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
Amorphous
Dissolution
Absorption
Solubility enhancement
Crystallization
Qi Guo
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
17
1.000
Imaging
PET
Neuroscience
Biomathematics
Analysis
Benjamin A Ellingson
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
Vishvas Garg
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
Health Economics and Outcomes Research
Ahmed Abbas Suleiman
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
21
16
0.762
Stephen Obrien
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Idiopathic Lung Fibrosis
Myopathies
diabetic nephropathy
renal osteodystrophy
podocytopathy
Vinayak Gupta
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
Covalent inhibitors
Organic synthesis
Cysteine Oxidation
Medicinal Chemistry
Junhai Yang
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
Mass spectrometry
Imaging mass spectrometry
Organic chemistry
pharmacetical
DMPK
Qili Fei
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
Kevin R Woller
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
29
15
0.517
Medicinal Chemistry
Targeted Protein Degradation
Parallel Synthesis
Organic Synthesis
Drug Discovery
Tiancheng He
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
15
0.625
Medical image analysis
Signal processing
Medical image computing
Maher Quraan
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
15
0.625
Dan Bow
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
17
15
0.882
Dan Cojocari
AbbVie Inc
Chicago, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
15
15
1.000
Biomarkers
Oncology
Cancer biology
Hypoxia
Apoptosis